BioSpace News Archive

PacBio announced financial results for the quarter and fiscal year ended December 31, 2022.

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the fourth quarter and full year ended December 31, 2022.

Penumbra, Inc. announced that its management team is scheduled to present at Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference on Thursday, March 2, 2023.

Nevro Corp. announced its fourth quarter and full-year 2022 financial results.

Blue Earth Diagnostics announced additional results from its Phase 3 LIGHTHOUSE trial that evaluated the diagnostic performance and safety of 18F-rhPSMA-7.3 in newly diagnosed prostate cancer.

Maze Therapeutics announced that the company will present data from its first-in-human clinical trial of MZE001 in healthy volunteers at the WORLDSymposium 2023.

Xencor, Inc. announced that it will report financial results for the fourth quarter and full year 2022 after the market closes on Thursday, February 23, 2023.

IVERIC bio, Inc. announced that the U.S. Food and Drug Administration has completed its filing review and accepted the company’s New Drug Application for avacincaptad pegol, a novel investigational complement C5 inhibitor for the treatment of geographic atrophy secondary to Age-Related Macular Degeneration.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced interim results from its pivotal Phase 3 safety and immunogenicity trial of mRNA-1010, an mRNA-based seasonal influenza vaccine candidate, in adults.

AMN Healthcare Services, Inc., the leader and innovator in total talent solutions for healthcare organizations across the United States, announced its fourth quarter and full year 2022 financial results.